首页> 美国卫生研究院文献>Cancer Science >Vincristine‐resistant Human Cancer KB Cell Line and Increased Expression of Multidrug‐resistance Gene
【2h】

Vincristine‐resistant Human Cancer KB Cell Line and Increased Expression of Multidrug‐resistance Gene

机译:长春新碱抗性人类癌症KB细胞系和多药耐药基因的表达增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A multidrug‐resistant clone of human cancer KB cells was isolated by stepwise selection on exposure to increasing doses of vincristine. The final clone, VJ‐300, obtained after ethylmethane sulfonate mutagenesis showed 400‐fold higher resistance to vincristine than did KB cells. Cellular accumulation of vincristine in VJ‐300 was decreased to less than one‐tenth of that in KB. The cells were also cross‐resistant to daunomycin, adriamycin, actinomycin D, colchicine and VP‐16. During continuous culturing in the absence of any drug for several months, a different colchicine‐resistant and multidrug‐resistant clone, KB‐C1, reverted almost completely to drug sensitivity, whereas drug resistance in VJ‐300 was stably maintained. Amplification of the multidrug‐resistance‐1 (mdr‐1) gene was more than 20‐fold in KB‐C1, but less than 2‐fold in VJ‐300, mdr‐1 mRNA was, however, expressed in VJ‐300 at a rate comparable to KB‐C1. Acquisition of high multidrug resistance in VJ‐300 might be correlated with both activated transcription of mdr‐1 gene and amplification.
机译:在逐渐增加的长春新碱剂量下逐步选择,从而分离出人类癌症KB细胞的多药耐药性克隆。甲烷磺酸乙酯诱变后获得的最终克隆VJ-300对长春新碱的抵抗力比KB细胞高400倍。 VJ-300中长春新碱的细胞积累减少到不到KB的十分之一。这些细胞对道诺霉素,阿霉素,放线菌素D,秋水仙碱和VP-16也具有交叉耐药性。在没有任何药物持续几个月的连续培养过程中,另一种耐秋水仙碱和多药耐药的克隆KB-C1几乎完全恢复了对药物的敏感性,而VJ-300的耐药性则得以稳定维持。在KB‐C1中多药耐药性1(mdr‐1)基因的扩增超过20倍,但在VJ‐300中扩增不到2倍,但是在VJ‐300中表达mdr‐1 mRNA速率可与KB-C1相媲美。 VJ-300中高耐药性的获得可能与mdr-1基因的激活转录和扩增都相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号